|
Antiplatelets
Citations 51-60 of 262 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Secondary Prevention in a Large Stroke Population. A Study of Patients' Purchase of Recommended Drugs
- Björn Wettermark, Anna Persson, and Mia von Euler
Stroke published August 7, 2008, doi:10.1161/STROKEAHA.107.513390
[Abstract]
- Original Contributions
Variables Associated With 7-Day, 30-Day, and 1-Year Fatality After Ischemic Stroke
- Gustavo Saposnik, Michael D. Hill, Martin O'Donnell, Jiming Fang, Vladimir Hachinski, Moira K. Kapral on behalf of the investigators of the Registry of the Canadian Stroke Network for the Stroke Outcome Research Canada (SORCan) Working Group
Stroke 2008;39:2318-2324; published online before print as doi:10.1161/STROKEAHA.107.510362
[Abstract]
[Full text]
- Articles
Synergistic Effect of an Endothelin Type A Receptor Antagonist, S-0139, With rtPA on the Neuroprotection After Embolic Stroke
- Rui Lan Zhang, Chunling Zhang, Li Zhang, Cindi Roberts, Mei Lu, Alissa Kapke, Yisheng Cui, Mitsuyoshi Ninomiya, Toshiaki Nagafuji, Bruce Albala, Zheng Gang Zhang, and Michael Chopp
Stroke published July 31, 2008, doi:10.1161/STROKEAHA.108.515684
[Abstract]
- Articles
Use of Ordinal Outcomes in Vascular Prevention Trials. Comparison With Binary Outcomes in Published Trials
- Philip M.W. Bath, Chamila Geeganage, Laura J. Gray, Timothy Collier, and Stuart Pocock
Stroke published July 31, 2008, doi:10.1161/STROKEAHA.107.509893
[Abstract]
- Articles
Escalating Levels of Access to In-Hospital Care and Stroke Mortality
- Gustavo Saposnik, Jiming Fang, Martin O'Donnell, Vladimir Hachinski, Moira K. Kapral, Michael D. Hill on behalf of the Investigators of the Registry of the Canadian Stroke Network (RCSN) for the Stroke Outcome Research Canada (SORCan) Working Group
Stroke published July 10, 2008, doi:10.1161/STROKEAHA.107.507145
[Abstract]
- Original Contributions
Influence of Socioeconomic Status and Gender on Stroke Treatment and Diagnostics
- Jasmin Arrich, Marcus Müllner, Wolfgang Lalouschek, Stefan Greisenegger, Richard Crevenna, and Harald Herkner
Stroke 2008;39:2066-2072; published online before print as doi:10.1161/STROKEAHA.107.506147
[Abstract]
[Full text]
- Emerging Therapies
The PREVAIL Trial and Low-Molecular-Weight Heparin for Prevention of Venous Thromboembolism
- Keith W. Muir
Stroke 2008;39:2174-2176; published online before print as doi:10.1161/STROKEAHA.107.509588
[Full text]
- Cochrane Corner
Antiplatelet Therapy in Aneurysmal Subarachnoid Hemorrhage
- Sanne M. Dorhout Mees, Walter M. van den Bergh, Ale Algra, and Gabriel J.E. Rinkel
Stroke 2008;39:2186-2187; published online before print as doi:10.1161/STROKEAHA.107.509257
[Full text]
- Articles
Variables Associated With 7-Day, 30-Day, and 1-Year Fatality After Ischemic Stroke
- Gustavo Saposnik, Michael D. Hill, Martin O'Donnell, Jiming Fang, Vladimir Hachinski, Moira K. Kapral on behalf of the investigators of the Registry of the Canadian Stroke Network for the Stroke Outcome Research Canada (SORCan) Working Group
Stroke published June 19, 2008, doi:10.1161/STROKEAHA.107.510362
[Abstract]
- Original Contributions
Dual Antithrombotic Therapy Increases Severe Bleeding Events in Patients With Stroke and Cardiovascular Disease: A Prospective, Multicenter, Observational Study
- Kazunori Toyoda, Masahiro Yasaka, Kazunori Iwade, Ken Nagata, Yukihiro Koretsune, Tomohiro Sakamoto, Shinichiro Uchiyama, Jun Gotoh, Takehiko Nagao, Masahiro Yamamoto, Jun C. Takahashi, Kazuo Minematsu for the Bleeding with Antithrombotic Therapy (BAT) Study Group
Stroke 2008;39:1740-1745; published online before print as doi:10.1161/STROKEAHA.107.504993
[Abstract]
[Full text]
|
|
